Regenxbio Inc (RGNX) — Strategic Asset Allocation Index
Regenxbio Inc (RGNX) has a Strategic Asset Allocation Index of 0.0% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $21.08 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check asset resilience ratio of Regenxbio Inc to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Regenxbio Inc Strategic Asset Allocation Index (2015–2025)
This chart shows how Regenxbio Inc's Strategic Asset Allocation Index has evolved across 11 annual periods from 2015 to 2025. As of March 2026, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $21.08 Million USD. See RGNX financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Regenxbio Inc (2015–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Regenxbio Inc from 2015 to 2025, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Regenxbio Inc (RGNX) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 10.5% | $10.79 Million | $- | $10.79 Million | $102.73 Million | ▲ +6.6 pp |
| 2024 | 3.9% | $10.18 Million | $- | $10.18 Million | $259.65 Million | ▼ -8.5 pp |
| 2023 | 12.5% | $38.87 Million | $- | $38.87 Million | $311.74 Million | ▼ -66.4 pp |
| 2022 | 78.9% | $407.36 Million | $206.80 Million | $200.56 Million | $516.20 Million | ▲ +2.2 pp |
| 2021 | 76.8% | $586.62 Million | $192.45 Million | $394.17 Million | $764.30 Million | ▲ +48.5 pp |
| 2020 | 28.2% | $106.54 Million | $56.47 Million | $50.08 Million | $377.75 Million | ▼ -3.5 pp |
| 2019 | 31.7% | $142.84 Million | $39.05 Million | $103.78 Million | $450.20 Million | ▼ -3.6 pp |
| 2018 | 35.3% | $179.52 Million | $28.70 Million | $150.82 Million | $508.85 Million | ▲ +19.1 pp |
| 2017 | 16.2% | $29.59 Million | $13.98 Million | $15.62 Million | $183.03 Million | ▼ -32.5 pp |
| 2016 | 48.7% | $78.74 Million | $9.32 Million | $69.41 Million | $161.74 Million | ▲ +1.1 pp |
| 2015 | 47.5% | $103.06 Million | $538.00K | $102.53 Million | $216.81 Million | — |